30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 936 participants.

Also called NCT01183013

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 936 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01183013
  • EudraCT 2008-008127-15
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Estonia, Germany, Latvia, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01183013. Randomized; double masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2014-04-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Pioglitazone 15 mg
Intervention (Drug)
Pioglitazone 45 mg
Intervention (Drug)
Pioglitazone 30 mg
Intervention (Drug)
Linagliptin 5mg / Pioglitazone 45 mg FDC
Intervention (Drug)
Linagliptin 5mg / Pioglitazone 30 mg FDC
Intervention (Drug)
Linagliptin 5mg
Intervention (Drug)
Linagliptin 5mg / Pioglitazone 15 mg FDC
Lead sponsor
Boehringer Ingelheim (class: industry)
Collaborator
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01183013
Content hash
e52aa85c23f9864ab767695534bf68ca48d02e0c4204ad8546b2abe6da2027d1